• FirefoxUpgrade to the new Firefox »
  •  Dow Up0.03% Nasdaq Up0.17%

    TG Therapeutics, Inc. (TGTX)

    -NasdaqCM
    16.03 Up 0.33(2.10%) Dec 24, 1:00PM EST
    Add to Portfolio
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingDec 31, 2013Dec 31, 2012Dec 31, 2011
    Total Revenue 152   19   -  
    Cost of Revenue -   -   -  
    Gross Profit 152   19   -  
    Operating Expenses
    Research Development13,663  21,028  327  
    Selling General and Administrative6,658  4,781  555  
    Non Recurring2,798  1,105   -  
    Others -   -   -  
    Total Operating Expenses -   -   -  
    Operating Income or Loss (22,966) (26,895) (882)
    Income from Continuing Operations
    Total Other Income/Expenses Net3,441  1,948   -  
    Earnings Before Interest And Taxes(19,525)(24,947)(882)
    Interest Expense953  906  7  
    Income Before Tax(20,478)(25,853)(889)
    Income Tax Expense -  330   -  
    Minority Interest -  8,110  36  
    Net Income From Continuing Ops(20,478)(18,073)(853)
    Non-recurring Events
    Discontinued Operations -   -   -  
    Extraordinary Items -   -   -  
    Effect Of Accounting Changes -   -   -  
    Other Items -   -   -  
    Net Income (20,478) (18,073) (853)
    Preferred Stock And Other Adjustments -   -   -  
    Net Income Applicable To Common Shares (20,478) (18,073) (853)

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.